Phosphoglycosyl transferases (PGTs) initiate the biosynthesis of both essential and virulenceassociated bacterial glycoconjugates including lipopolysaccharide, peptidoglycan and glycoproteins. PGTs catalyze the transfer of a phosphosugar moiety from a nucleoside diphosphate sugar to a polyprenol phosphate, to form a membrane-bound polyprenol diphosphosugar product. PGTs are integral membrane proteins, which include between 1 and 11 predicted transmembrane domains. Despite this variation, common motifs have been identified in PGT families through bioinformatics and mutagenesis studies. Bacterial PGTs represent important antibacterial and virulence targets due to their significant role in initiating the biosynthesis of key bacterial glycoconjugates. Considerable effort has gone into mechanistic and inhibition studies for this class of enzymes, both of which depend on reliable, high-throughput assays for easy quantification of activity. This review summarizes recent advances made in the characterization of this challenging but important class of enzymes.
This review will focus on bacterial PGTs, however, it is important to note that PGTs are also found in eukaryotes. For example, a PGT catalyzes formation of Pren-PP-GlcNAc on the cytoplasmic face of the endoplasmic reticulum membrane, initiating the dolichol pathway towards N-linked protein glycosylation (Burda and Aebi 1999) . In eukaryotes the linear polyprenols are saturated at the α-isoprene unit and are referred to as "dolichols" (Hartley and Imperiali 2012) . Interestingly, for selected archaea wherein glycoprotein biosynthesis pathways have been studied in biochemical detail, including Haloferax volcanii (Kaminski et al. 2010) and Methanococcus voltae (Larkin et al. 2013 ) the biosynthesis of N-linked glycoproteins is not initiated with a PGT-catalyzed process. Instead, a GT catalyzes the transfer of a single carbohydrate from an NDP-linked sugar to a Pren-P to form an α-linked Pren-P-sugar.
Despite their importance in glycobiology, advances in structural and functional characterization of PGTs have proceeded at a relatively slow pace. This review describes the challenges associated with studying this class of integral membrane proteins, and highlights the progress made in the classification, isolation and characterization of bacterial PGTs since a comprehensive review in 2005 (Price and Momany 2005) . A summary of the design and development of PGT inhibitors based on natural products is also presented.
An evolving classification of PGTs
PGTs have been classified based on the structures of their NDPactivated sugar substrates, the predicted topologies of known PGTs, and based on whether the origin of the enzymes is prokaryotic or eukaryotic (Valvano 2003) . This classification describes two families of PGTs: polyisoprenol-phosphate hexose-1-phosphate transferases (PHPTs), which are observed to only occur in bacteria and polyisoprenol-phosphate N-acetylaminosugar-1-phosphate transferases (PNPTs), which are found in both prokaryotes and eukaryotes (Valvano 2003) . PHPT enzymes generate polyprenol-PP-hexose products, while PNPT enzymes produce polyprenol-PP-HexNAc products. This method of PGT classification was initially valuable for predicting the function of enzymes based on sequence similarity.
As PGTs with substrate preferences and predicted structures beyond the original definition continue to be discovered it is evident that the relationship between enzyme substrate and structure is more complex. Sequence homology and functional analyses reveal that the known PGTs are represented as two distinct superfamilies with divergent overall predicted topologies and mechanisms of action (see Figure 2A , B). PGTs, including WecA and MraY, belong to a superfamily with a polytopic membrane architecture including 10-11 predicted transmembrane helices (TMHs) (Anderson, Eveland, Price 2000) . Bacterial members of the WecA family transfer GlcNAc-1-phosphate from UDP-GlcNAc to a Pren-P acceptor, initiating the O-antigen and enterobacterial common antigen biosynthesis (Lehrer et al. 2007) . Eukaryotic members of the WecA family include the GlcNAc-1-phosphate transferases (GPTs) that initiate Nlinked protein glycosylation at the beginning of the dolichol pathway by transferring GlcNAc-1-phosphate to dolichol phosphate (Lehrman 1991; Burda and Aebi 1999) . Members of the MraY family catalyze the transfer of 1-phospho-MurNAc-pentapeptide (L-Ala-γ-D-Glu-diaminopimelic acid/L-Lys-D-Ala-D-Ala, also called Park's nucleotide) to undecaprenol phosphate, on the cytoplasmic face of the plasma membrane. The glycan component of the reaction product is then flipped across the membrane, and crosslinked with release of the Pren-PP to form peptidoglycan .
A second superfamily of PGTs with a distinct architecture based on primary structure is also prevalent (Saldias et al. 2008; Hug and Feldman 2011; Lukose et al. 2015) . Key contributions defining this superfamily came from studies on a PGT designated as WbaP from Salmonella enterica, which initiates O-antigen biosynthesis in bacteria (Saldias et al. 2008) . WbaP is a polytopic membrane protein with five predicted TMHs, however, it has been shown that this PGT can be truncated, to remove four of the five N-terminal TMHs, and still preserve both in vivo (Patel et al. 2010 ) and in vitro (Patel et al. 2012) activity. Therefore, the minimal structural and functional core comprises a single predicted membrane-associated domain (ca. 22 amino acids) and a small globular cytoplasmic domain (ca. 180 amino acids).
Two other PGT families contain domains that share homology with the functional core of WbaP and are therefore members of the second superfamily. The two families are represented by the Campylobacter jejuni PglC (Glover et al. 2006; Szymanski et al. 1999) which catalyzes the first membrane-committed step in a bacterial N-linked protein glycosylation, and the Neisseria gonorrhoeae PglB (Hartley et al. 2011) , which is a bifunctional enzyme including Fig. 1 . Phosphoglycosyl transferases (PGTs) initiate the biosynthesis of glycoconjugates at membrane interfaces by forming polyprenol-PP-linked sugars that are elaborated by glycosyltransferases (GTs). During biosynthesis the polyprenol-PP-linked glycans may be actively flipped across the membrane to serve as substrates for transfer to acceptor molecules, such as lipids or proteins. The complex glycoconjugates from these pathways participate in a variety of important biological processes. This figure is available in black and white in print and in color at Glycobiology online.
an N-terminal PGT domain, with the same functional core as the fulllength PglC, and a C-terminal amino-sugar acetyl transferase domain. The N. gonorrhoeae PglB functions at the initiation of a bacterial O-linked protein glycosylation pathway. In contrast to the eukaryotic pathways, the N-and O-protein glycosylation pathways of bacteria both involve the assembly of a glycan that is ultimately transferred en bloc from the Pren-PP-sugar donor to a protein acceptor.
Recent bioinformatics analysis on 15,000 bacterial sequences from these three related PGT families underscores the relationships within this superfamily and highlights conserved residues (Lukose et al. 2015) . As illustrated in Figure 2B , the three superfamily members share a common domain that is represented in the simplest family member PglC, but may incorporate additional N-or C-terminal domains. It is also evident from this study and from previous analyses of the WbaP family (Patel et al. 2012 ) that all members of this PGT superfamily include a highly conserved proline residue in the predicted transmembrane helix (TMH) that is part of the minimal PGT functional core. Furthermore, this proline is important for function (Lukose et al. 2015) . The membrane disposition of this conserved feature of the PGT sequences was recently examined in detail for the Escherichia coli WcaJ, which is a homolog of WbaP that is involved in the colonic acid exopolysaccharide biosynthesis (Furlong et al. 2015) . By applying a combination of LacZ/PhoA reporter fusions and unique cysteine labeling using the substitutedcysteine accessibility method (Nasie et al. 2013) , evidence was provided that the proline-containing helix common to this superfamily of PGTs is not a TMH, but rather a reentrant membrane helix (RMH) ( Figure 2C ). This result underscores the importance of experimental determination of membrane topology, since none of the five membrane-prediction algorithms employed in the study correctly predicted the RMH (Furlong et al. 2015) . Given the common functional domain shared by the three families, the topological feature observed in WcaJ is likely to be shared amongst the corresponding domains in the related PglB(Ng) and PglC families. Therefore, similar analyses should be performed to clearly define the topology in native proteins in vivo to confirm the classification and topologies of PGTs.
Given the evidence to date, predicted membrane topologies and common structural cores together with biochemical validation are the most reliable determinants by which PGTs can be classified into superfamilies with unique topological and functional attributes. The structural diversity observed among bacterial PGTs represents an example of convergent evolution, where integral membrane proteins with vastly different structures catalyze the same basic reaction. From a biochemical perspective, this structural variation raises important questions about the similarities and differences between the catalytic and substrate-binding domains present in inter-helix loops of the polytopic PGT superfamily and those present in cytoplasmic and membrane-associated domains of the PGT superfamily with the common PglC-like core. The diversity in membrane topologies also raises questions about the roles of the membrane-associated domains in binding and catalysis, especially with respect to protein-protein interactions in the membrane and binding to the membrane-associated Pren-P substrate.
Common motifs in PGT families
Bioinformatics analysis and mutagenesis studies have provided information about motifs conserved within and among different PGT families. In particular, sequence alignments revealed conserved signature sequences in loops between the TMHs in the WecA and MraY families. The significance of these motifs was investigated by selectively mutating conserved residues and analyzing the activity of the resulting proteins. For example, both families have a conserved DDXXD motif, in which the adjacent aspartate residues are believed to coordinate the essential metal ion cofactor (Lloyd et al. 2004) . A recent crystal structure of MraY supports this hypothesis (Chung et al. 2013 ). Both families also have conserved motifs with multiple histidine residues (HIHH in the WecA family, and MAPIHHHFEL in the MraY family), which are thought to play a role in recognition 4 0 1 1 6 9 9 9 2 7 3 3 5 9 1 4 1 1 6 3 1 9 2 1 7 0 2 1 9 1 9 7 2 5 4 2 3 2 2 8 1 2 5 9 3 0 8 2 8 6 3 5 6 3 3 7 1 5 2 4 8 9 7 0 6 6 4 5 3 6 7 1 0 5 1 2 7 1 5 3 1 3 1 1 8 4 1 6 0 2 1 3 2 0 6 2 4 2 2 3 2 2 9 4 2 6 1 1 7 9 3 1 1 1 3 2 1 3 3 8
A of the carbohydrate substrate, although the exact interactions between these motifs and the substrates have not been established (Anderson et al. 2000; Amer and Valvano 2001) . WecA and related family members also feature a conserved VFMGD motif, which is believed to contribute to the active site of the enzymes and to be involved in product release (Furlong and Valvano 2012) . Similar studies with the C-terminal domain of proteins in the WbaP family have also revealed residues important for catalytic activity (Patel et al. 2010) . Recent bioinformatics studies and functional analysis (Lukose et al. 2015) of members of the PglC, PglB(Ng) and WbaP families have also provided insight into residues required for the catalytic activity of these PGTs including a highly conserved AspGlu (DE) dyad. Importantly, the motifs identified in these studies are distinct from those found in the polytopic PGT family.
Sugar substrate specificity of PGTs
Protein sequence and topology can be useful to classify PGTs, but does not provide conclusive evidence of substrate specificity. Enzymes within the same family can have different sugar substrates, some of which are highly modified and are synthesized only by bacteria ( Figure 3 ) (Szymanski and Wren 2005) . These modified UDPsugar substrates may not be commercially available, which also hampers PGT characterization. For example, UDP-diNAcBac, the substrate for PglC, is biosynthesized in a three-step enzymatic sequence (redox-dependent dehydration, amination, and aminoacetylation) from UDP-GlcNAc. UDP-diNAcBac can also be synthesized chemically (Weerapana et al. 2005) , however, chemoenzymatic synthetic strategies are more tractable and have allowed the characterization of enzymes that use UDP-diNAcBac (Olivier et al. 2006; Hartley et al. 2011; Morrison and Imperiali 2013) . The MurNAcpentapeptide substrate of MraY is a UDP-GlcNAc moiety decorated with a lactyl-pentapeptide chain at the C-3′ position, and also represents a complex donor substrate that is not commercially available. In this case, a chemoenzymatic approach can provide good access to UDP-MurNAc-pentapepide (Kurosu et al. 2007 ).
Bioinformatics analysis can be used to identify PGTs based on sequence homology to characterized enzymes, however, the specificities of these enzymes cannot yet be predicted based on sequence alone, and the substrates of many of these PGTs have yet to be identified by biochemical techniques. If the sugar substrates of these newly identified PGTs are highly modified and not commercially available, they must be synthesized, which adds to the challenge of characterizing a PGT of interest and conclusively determining its substrate specificity.
Polyprenol specificity of PGTs
The products of PGT reactions are precursors for the biosynthesis of complex glycoconjugates featuring the Pren-PP moiety, which serves both as a membrane anchor and an activating group for the ultimate transfer to acceptor substrates. The long-chain linear polyprenols that feature in glycan assembly pathways are classified based on the saturation state of the α-isoprene unit. Undecaprenol and related polyprenols of different lengths comprise a linear polymer of unsaturated isoprene units. In contrast, dolichols feature a saturated isoprene unit in the α-position of the polymer (Figure 4 ). Bacteria typically exploit polyprenols with unsaturated α-isoprene units, while archaea and eukarya use dolichols (Jones et al. 2009; Hartley and Imperiali 2012) .
The availability of polyprenol phosphates with the desired chain length and cis/trans geometry can be a limiting factor in determining substrate specificities of PGTs. The isolation of pure polyprenol phosphates from native organisms is often challenging and low-yielding (Adair and Keller 1985) . Furthermore, although some linear polyprenols are commercially available, the high cost limits the scope of the biochemical and biophysical studies that are required to fully characterize enzyme activity. Interestingly, certain plants contain high levels of linear unsaturated polyprenols of varying lengths, and have proven to be a valuable source of isoprenoids for biochemical studies Fully unsaturated polyprenol phosphate and (B) dolichol phosphate. The length of the polyprenol and the number of isoprene units varies. The "m" denotes the number of cis isoprene units and "n" is the number of trans isoprene units. The value of "m" ranges from 12 to 37 in eukaryotes, and the value of "n" ranges between 2 and 3. For example, bacterial undecaprenol double bonds are m = 8 and n = 2 and plant-derived undecaprenols are m = 7 and n = 3. (Jankowski et al. 1994) . Once isolated, the polyprenols can be regioselectively hydrogenated (Imperiali and Zimmerman 1988; Larkin et al. 2013 ) to afford dolichols and/or phosphorylated using chemical or chemoenzymatic methods (Hartley et al. 2008 ) to obtain substrates that can be used to biochemically characterize PGTs from all domains of life (Hartley and Imperiali 2012) .
The specificity of PGTs for their Pren-P substrates has been evaluated by varying the carbon chain length and saturation of the α-isoprene unit of these substrates. WecA from Thermatoga maritima is active with polyprenol phosphates with 10 and 35 carbons and shows reduced activity when tested with polyprenols longer than the native C 55 substrate (Al-Dabbagh et al. 2008 . Interestingly, WecA appears to achieve 60% activity compared to undecaprenol phosphate when tested with dolichol (C 55 ) phosphate (Al-Dabbagh et al. 2008) . MraY shows even broader substrate specificity, forming products with dolichol (C 40 ) phosphate, polyprenol (C 35 ) phosphates, and even the shorter, water-soluble prenol phosphate substrates with as few as 10 carbons; however, the shorter prenol-diphosphate-linked substrates show much poorer turnover (Breukink et al. 2003) . Analysis of the substrate specificity of the C. jejuni PglC reveals that the doublebond geometry and unsaturation in the α-isoprene unit are more important for substrate recognition than the overall number of isoprene units (Chen et al. 2007) . Studies with the PglC-like domain of WbaP demonstrate that this domain appears to be very selective for undecaprenol phosphate, and is unable to tolerate Pren-P substrates with fewer than 50 carbons (10 isoprene units) (Patel et al. 2012) . Both PglC and the C-terminal domain of WbaP show minimal activity with longer dolichol phosphates (Chen et al. 2007; Patel et al. 2012 ).
Overexpression and purification of PGTs
PGTs represent potential antibiotic targets due to the significance of their glycoconjugate products, particularly in pathogenic bacteria (Tytgat and Lebeer 2014) . However, PGTs are integral membrane proteins, and are particularly recalcitrant to efficient heterologous overexpression. Obtaining pure, stable protein remains a significant challenge in the characterization of these membrane-bound enzymes (Newby et al. 2009 ). First, overexpression of membrane proteins in host organisms such as E. coli may result in the accumulation of large amounts of a non-native protein in cell membranes, which can be cytotoxic (Wagner et al. 2007 ). Additionally, since integral membrane proteins contain many hydrophobic domains, they are extremely prone to aggregation over the course of protein overexpression and purification. The most destabilizing step in purification is the extraction of proteins from native membranes and solubilization into detergent micelles, which always demands considerable optimization. Additionally, the best detergent for extraction may not necessarily be the detergent that affords the most active form of the protein; thus, optimization of detergents at multiple steps is required (Al-Dabbagh et al. 2008) . Cell-free protein expression shows promise as an alternative method for large-scale membrane protein production, as it avoids the challenges associated with cell toxicity and resolubilization into detergent micelles. This technique has been used to produce quantities of MraY (Ma et al. 2011; Henrich et al. 2016) .
Due to the complications encountered in obtaining pure, stable protein, many initial studies to characterize PGTs were performed with crude membrane preparations or detergent-solubilized membrane fractions. Although these studies provided insight into the PGTs enzymes, precise quantitative data often could not be obtained because the exact quantity and purity of the proteins was unknown. Challenges associated with obtaining stable protein have impeded crystallographic studies with PGTs, and to date MraY is the only PGT that has been structurally characterized (Chung et al. 2013 ).
PGT activity assays
The PGT reaction involves the transfer of a phosphosugar from an aqueous-soluble NDP-sugar substrate to a membrane-bound Pren-P acceptor. Assays have traditionally exploited this difference in solubility between the starting materials and products by analyzing the reaction using extraction-based and related separation techniques. Due to the potential of these enzymes as therapeutic targets, a great deal of effort has gone into developing high-throughput assays to apply to inhibitor screening.
The transfer of a phosphosugar, which is radiolabeled in the carbohydrate moiety, from an NDP-sugar to unlabeled Pren-P acceptors, can be quantified using liquid-liquid extraction or by thin layer and HPLC chromatography ( Figure 5B , C) (Behrens and Tabora 1978; Bouhss et al. 2004; Patel et al. 2012; Stachyra et al. 2004; Patel and Valvano 2013) The extraction approach has also been further developed into a high-throughput solid-liquid extraction-based assay using hydrophobic polymer beads. The beads are added to quenched reactions in a microwell plate format to selectively bind to the Pren-PP-linked substrate. After filtering and washing steps, the bound product is quantified using scintillation counting. This method can be applied in coupled assays and has been tested successfully with MraY, WecA, and a coupled MraY/MurG system (Hyland and Anderson 2003) . However, the approach still relies on the availability of radiolabeled NDP-sugar substrates and thus would be mostly limited to commercially available substrates.
The majority of PGT assay development has focused on the reaction catalyzed by MraY, due to its importance as an antibiotic target. Initial assay strategies have exploited fluorescently labeled variants of Park's nucleotide in which the ε-amino group of the lysine residue was modified with a fluorophore. This approach has been most successful for MraY due to the modularity and relative promiscuity of the enzyme for the pentapeptide substrate, which allows for fluorophore modification of the substrate without affecting substrate binding or activity. When a dansyl group is used as solvatochromic fluorophore in the MraY substrate, a change in the emission wavelength is observed upon transfer of the fluorophore-conjugated glycopeptide moiety to a hydrophobic environment, providing a signal with which enzyme activity can be monitored (Weppner and Neuhaus 1977; Wohnig et al. 2016) . Fluorescein isothiocyanate has also been used successfully to label sugars for activity and inhibition assays, with the analysis performed after liquid-liquid extraction or by chromatography ). Modifications to this assay include use of shorter polyprenols to increase water solubility. Prenols with as few as three isoprene units have been found to be suitable substrate analogs for MraY and afford robust enzyme turnover (Mitachi et al. 2015) . A FRETbased assay using a BODIPY as a fluorescence donor in the MurNAcpentapeptide substrate and a fluorophore-labeled phospholipid as the acceptor has also been developed for high-throughput screening of MraY inhibitors (Shapiro et al. 2012) .
Recently, the Imperiali group has adapted the UMP/CMP-Glo assay, which is a luminescence-based assay developed by Promega that detects UMP (or CMP) release ( Figure 5A ). Advantageously, this assay does not require substrate labeling, and can therefore be used to investigate PGT enzymes with diverse and unique carbohydrate specificities. The detection method is compatible with high-throughput screening formats using 96-and 384-well plates. UMP/CMP-Glo has been used successfully to characterize the activities of PGTs with varying structures and UDP-sugar substrates, demonstrating the versatility of approach (Das et al. 2016) .
Mechanistic investigation of the PGT reaction
The PGT reaction is isoenergetic, involving the cleavage of a diphosphate bond in the UDP-sugar substrate, and formation of a diphosphate bond in the Pren-PP-linked product. The reaction formally involves nucleophilic attack of Pren-P on the α-linked phosphate of an NDP-sugar resulting in transfer of a sugar-1-phosphate to form a Pren-PP-linked carbohydrate. Two mechanisms can be proposed for this bisubstrate reaction-a Bi Bi ping-pong mechanism with the formation of a covalent intermediate, or a Bi Bi random or ordered mechanism with intermediate formation of a ternary complex (Figure 6 ). Importantly, both mechanisms result in retention of stereochemistry at the anomeric center of the sugar since the reaction occurs at the adjacent phosphorus center. Kinetic analysis of the eukaryotic GPT, a polytopic PGT in the WecA family, has suggested a Bi Bi random mechanism, with formation of a ternary complex for this enzyme (Keller et al. 1979 ). In contrast, early studies with MraY initially suggested that transfer of the MurNAcpentapeptide occurred via formation of an acyl phosphate intermediate involving an aspartic acid residue in MraY (Lloyd et al. 2004) . However, these studies may have been ambiguous as they were performed with crude membrane protein fractions. More recently, both WecA and MraY have been purified to homogeneity and now, studies with purified protein strongly support that both enzymes proceed through the formation of a ternary complex mechanism, without formation of a covalent intermediate (Al-Dabbagh et al. 2016) , suggesting that this may be a common feature of the polytopic PGT superfamily.
In contrast to the studies with the polytopic PGTs, a recent investigation of the reaction mechanism of PglC from C. concisus supports a Bi Bi ping-pong mechanism (Das et al. 2017) . In this case, evidence is provided to support a mechanism, which proceeds through a two-step mechanism involving first nucleophilic attack by an active site aspartic acid residue on the α-linked phosphate of the NDP-sugar substrate to form a covalent phosphosugar intermediate. The key aspartic acid is part of the Asp-Glu dyad that is highly conserved in the 15,000-sequence analysis of the superfamily of PGTs that share the PglC-like structural core (Lukose et al. 2015) . In the second step of the mechanism the covalent enzyme intermediate is subject to attack by Pren-P to complete the PGT reaction.
PGT inhibitors based on nucleoside antibiotics
Inspired by the centrality and essentiality of PGTs in the assembly of bacterial glycoconjugates, these enzymes are important targets for inhibitor design with the goal of developing novel antimicrobial and antivirulence agents. Currently, there is only limited structural information on PGTs, due to their challenging topologies (vide supra) and poor expression in heterologous systems. Therefore, efforts towards the development of PGT inhibitors have centered on inspiration from the structures of nucleoside antibiotics, which have emerged from natural product screening campaigns (Elshahawi et al. 2015) . Many of these structurally complex compounds are secondary metabolites produced by Streptomyces species that display a wide variety of biological activities, including antibacterial, antifungal, antiviral and antitumor activity (Niu and Tan 2015) . For the purpose of this review, we will focus on a selection of well-known natural products with an emphasis on their structural differences and enzyme target selectivity. The potential of nucleoside antibiotics to serve as inspiration for novel antimicrobials, and synthetic efforts towards derivatives thereof have recently been reviewed (Ichikawa et al. 2015; Serpi et al. 2016; Wiegmann et al. 2016) .
Tunicamycin was the one of the first nucleoside antibiotics to be discovered (Figure 7 ) (Takatsuki et al. 1971) , and since its discovery in the 1970s it has been used in numerous biological studies due to its potent inhibition of protein glycosylation in eukaryotic cells. The structure of tunicamycin reveals the 11-carbon dialdose sugar, tunicamine, which includes a uridine moiety, connected via a carbon-carbon linkage to a central pseudo-GalNAc moiety. Tunicamine is in turn connected to GlcNAc through a 1,1′-linkage, and N-acylated with a long-chain fatty acid. Tunicamycin has high affinity for the GPT, also known as Alg7, which is the eukaryotic PGT that initiates the dolichol pathway (Heifetz et al. 1979) . Specifically, tunicamycin arrests Nlinked glycoprotein biosynthesis in the endoplasmic reticulum by inhibiting formation of dolichol diphospho-GlcNAc (Dol-PP-GlcNAc), and therefore is highly toxic to humans (Zeng and Elbein 1995; Scocca and Krag 1997) . Tunicamycin also potently inhibits WecA (Al-Dabbagh et al. 2008) , which is a bacterial PGT that also uses UDP-GlcNAc. In contrast to the potent inhibition of Alg7 and WecA, tunicamycin displays only moderate inhibition of MraY, which transfers 1-phospho-MurNAc-pentapeptide (Inukai et al. 1993 ). The tunicamycins are structurally related to the streptovirudins and corynetoxins, which differ in the fatty acid composition (R 1 in Figure 7 ).
The mureidomycins were characterized in 1989, and contain a unique enamide moiety attached to a 3′-deoxyribose unit (Figure 7 ) (Isono et al. 1989 ). The mureidomycins share structural features with the pacidamycins, sansanmycins, and napsamycins, which display alternative side chains at the R 2 to R 5 positions, and none has a fatty acid moiety (Ichikawa et al. 2015) . Mureidomycin potently inhibits MraY, and a putative mode of binding has been described based on competition studies with both carbohydrate and lipid substrates (vide infra). Interestingly, mureidomycin has low affinity for the eukaryotic GPT, suggesting that target specificity for bacterial PGTs could be exploited in the quest for new antibiotics. However, the enamide linkage has limited general applications of the mureido scaffold in medicinal chemistry approaches. Of all nucleoside antibiotics, the muraymycins have gained the most attention from the scientific community because of their antibiotic potential through inhibition of MraY. First isolated in 2002, muraymycins are characterized by a glycyl-uridine motif, an aminoribose, a urea moiety and a fatty acid (Figure 7 ) (McDonald et al. 2002) . The active site of MraY is located in the cytoplasm, and the fatty acids of the muraymycins are thought to facilitate uptake to confer antimicrobial activity.
Finally, the caprazamycins and liposidomycins share a unique diazepanone ring, adjacent to the aminoribose unit and a fatty acid (Figure 7 ) (Isono et al. 1985; Igarashi et al. 2003 Igarashi et al. , 2005 . These natural products are known to inhibit MraY activity, and the caprazamycins have also shown inhibition of WecA and TagO, which is a PGT with UDP-GlcNAc specificity involved in teichoic acid biosynthesis (Ishizaki et al. 2013 ).
Together, the nucleoside antibiotics form an interesting class of complex structures to inspire the next generation of PGT inhibitors. However, care has to be taken in interpreting the results from PGT inhibition studies. The reported antimicrobial potencies of the nucleoside antibiotics against different target PGTs are difficult to compare, as the assays on membrane-bound PGTs are not standardized. Data on whole cells, solubilized membrane fractions, and purified proteins cannot be compared, as nonspecific interactions as well as variable cellular uptake greatly influence potency. Moreover, while IC 50 values are commonly cited, these can only be compared as relative values within a set of identical assays as they are condition-dependent parameters that are influenced by substrate concentrations and enzyme preparations. In addition to challenges with expression and purification, as presented previously, PGT activity is difficult to assess, since the assays are labor-intensive, and do not allow straightforward inhibitor screening. Ultimately, perhaps the most reliable comparison is the minimum inhibitory concentrations (MIC values) against the same bacterial strains, but that assumes prior validation of the mode of action and comparable bioavailability.
PGT inhibitors: mechanism of action
Nucleoside antibiotics are potent inhibitors of PGTs, and a great deal of effort has gone into exploring the mechanisms of inhibition of these diverse compounds. In particular, tunicamycin is proposed to be a bisubstrate analog inhibitor of selected PGTs, because it includes features from both the sugar-nucleotide and polyprenol phosphate substrates (Keller et al. 1979) . However, detailed studies have revealed that the inhibition mechanism may be less straightforward. In one study, Brandish et al. investigated the mode of inhibition of MraY by tunicamycin, mureidomycin and liposidomycin, using substrate competition analysis (Brandish et al. 1996) . These studies showed that although these three classes of compounds shared some common structural features, the mechanism of inhibition varied greatly. For example, with MraY, tunicamycin was found to be competitive for the UDP-MurNAc-pentapeptide substrate, but not for the Pren-P substrate, even though it has a fatty acyl component that could potentially bind in a polyprenol binding site. Interestingly, mureidomycin was found to be competitive for both substrates, and liposidomycin was only competitive for the Pren-P substrate (Brandish et al. 1996) . Using molecular modeling and energy minimization, the different inhibitors have been superimposed with UDP-MurNAc, starting with the common uridine motif (Dini et al. 2000) . The studies suggested that the GlcNAc moiety of tunicamycin might superimpose with the MurNAc moiety. Also, the diphosphate functionality in UDP-MurNAc may be mimicked by the pseudo-GalNAc moiety in tunicamycin, and similarly by the aminoribose unit in liposidomycin. In the case of tunicamycin, NMR studies corroborated the proposal that the pseudo-GalNAc moiety serves as a diphosphate mimic, because it is ideally positioned to coordinate to the divalent metal ion in the PGT active site (Xu et al. 2004) . A similar binding mechanism was proposed for mureidomycin, in which a protonated amine binds the DDxxD motif, instead of the divalent metal ion (Howard and Bugg 2003) . Major advances in the field include the recently published structures of MraY co-crystallized with muraymycin D2 (Chung et al. 2016) and tunicamycin (Hakulinen et al. 2017) . In comparison to the MraY apo structure published previously (Chung et al. 2013) , the inhibitor-bound structures revealed that MraY undergoes a large, but similar conformational change upon binding of either inhibitor. In contrast to tunicamycin, muraymycin seems to have little interaction with the catalytically-important amino acid residues. Docking studies based on the co-crystal structures suggested that the uracil and ribose moieties of UDP-GlcNAc overlap well with these functionalities in tunicamycin (Hakulinen et al. 2017) , as proposed previously (Dini et al. 2000) .
With regard to the eukaryotic GPT, such as the Saccharomyces cerevisiae Alg7, there are contradicting reports on the mechanism of inhibition by tunicamycin. In one report, tunicamycin was found to be competitive with the UDP-GlcNAc substrate (Keller et al. 1979) , while another report suggested that tunicamycin is noncompetitive with respect to the concentrations of either substrate, suggesting an alternative mode of inhibition (Heifetz et al. 1979) . Sequence alignment of human GPT with crystallized MraY revealed amino acid differences in the regions involved in substrate/inhibitor binding (Hakulinen et al. 2017) . This reinforces the possibility that a different mechanism of GPT inhibition may be relevant, and creates opportunities to selectively target MraY over GPT. The contradicting biochemical results illustrate the difficulties associated with comparing inhibition data; the two GPT studies use different sources of solubilized GPT-containing cell fractions and different activity assays, which may have led to different conclusions. Interestingly, the different binding modes of tunicamycin and muraymycin to MraY illustrate the challenge in understanding the mode of PGT inhibition by the nucleoside antibiotics.
Chemical approaches to analogs of nucleoside antibiotics
Efforts to utilize nucleoside antibiotics as lead structures and inspiration for inhibitor development have mainly focused on MraY as the target for two reasons (Winn et al. 2010) ; MraY has an essential role in bacterial survival, and a fluorescently-labeled versions of Park's nucleotide are available, allowing quantification of enzyme activity using fluorescence-based approaches, which are not readily applicable to PGTs that act on simple NDP-sugar substrates.
From the previous section it is clear that it is experimentally quite challenging to decipher the exact mode of inhibition of the nucleoside antibiotics. Chemical synthesis has played a large role in understanding the binding modes of these compounds by generating derivatives to test in inhibition experiments. Because of the complex chemical structures of all classes of natural product-based nucleoside antibiotics, only few reports describe efforts towards the total synthesis of nucleoside antibiotics, including muraymycin (Tanino et al. 2010; , tunicamycin (Suami et al. 1983 (Suami et al. , 1984 Myers et al. 1991 , 1993a , 1993b , Li and Yu 2015 , and pacidamycin (Okamoto et al. 2012b) . Rather, chemists have started with the minimal scaffolds needed to obtain binding, and have elaborated on these using various methods. The majority of efforts have focused on derivatives of muraymycin, and some synthetic strategies will be highlighted here.
Starting from muraymycin, the minimal scaffold needed for inhibition was found to be the aminoribosyl-O-uridine scaffold 1 (Dini et al. 2000) , where an additional hydroxymethyl group with the (S)-configuration increased inhibitory potency (2, Figure 8 ). The group of Gravier-Pelletier reported a diversity-oriented synthesis method to easily obtain various analogs of scaffold 2, in which the hydroxymethyl moiety was replaced by an azide or alkyne (3 and 4, Figure 8 ) (Fer et al. 2013 (Fer et al. , 2015 . A subsequent copper(I)-catalyzed cycloaddition reaction with diverse alkynes or azides (CuAAC), respectively, allowed for screening various lipophilic moieties. IC 50 values were found to be in the low μM range, and seemed to be competitive with the nucleotide substrate. Matsuda and co-workers developed an activity-driven approach to increase the antibacterial activity of muraymycin D2, which was found to be highly potent against purified MraY in vitro (IC 50~0 .01 μM), but not in whole cell assays (Tanino et al. 2010 . Using an Ugi four-component reaction (U4CR), muraymycin D2 derivatives (5, Figure 8 ) were assembled that displayed various lipophilic side chains (R 1 ) and peptidic components (R 2 ). Interestingly, while the inhibitory activity with purified MraY decreased by 10-fold, the antibacterial activity, especially for Gram-negative bacteria, was significantly increased in different bacterial strains by the introduction of a lipophilic moiety (Takeoka et al. 2014) . Ducho and co-workers revealed that the aminoribose moiety is not necessary for antibacterial activity, and developed an elegant synthesis towards a simplified muraymycin-based scaffold (6 in Figure 8 ) that is a promising lead for further development (Spork et al. 2014 ). Ichikawa and co-workers have developed a lactam-fused isoxazolidine scaffold as a simplified structural analog of muraymycin and caprazamycin (7, Figure 8 ) . When connected to a uridine moiety and a lipophilic side chain, comparable MIC values to the parent compounds were obtained.
The U4CR was also successfully applied to the pacidamycin scaffold (Okamoto et al. 2012a) , which is a structural analog of mureidomycin. Using cleverly designed building blocks, pacidamycin D (8, Figure 8 ) and an arsenal of derivatives were generated, which provided detailed information on the structure-activity relationship of MraY inhibition, and Pseudomonas aeruginosa MIC values. In an alternative "mutasynthesis" (Weissman 2007 ) approach, Goss and co-workers have reported a biosynthetic approach to pacidamycin derivatives by hijacking the natural product biosynthesis machinery in Streptomyces coeruleorubidus (Gruschow et al. 2009; Ragab et al. 2010) . When S. coeruleorubidus cultures were supplemented with tryptophan or tyrosine analogs, the amino acids were incorporated into newly-synthesized pacidamycins. Therefore, this strategy provides an alternative platform for tailoring new pacidamycin analogs.
Recent research from the Imperiali group revealed that the combination of specific chemical moieties together yielded inhibitors with μM IC 50 values . The inhibitors were inspired by the structures and postulated binding modes of mureidomycin A (Gentle et al. 1999) and tunicamycin ( Figure 9 ) (Price and Momany 2005) , and were designed in such a way that they displayed: (1) a uridine moiety, (2) a primary amine or carboxylate, to substitute or coordinate the metal ion in the active site, (3) a side chain (R) to occupy the carbohydrate-binding site and (4) an alkyl chain to as a surrogate for the prenyl moiety in the acceptor substrate. The resulting scaffolds are highly modular and can be easily be differentiated to investigate structure-activity relationships and target selectivity.
Taken together, all of these examples illustrate the power of organic chemistry in understanding the features of the scaffolds that are important for the generation of PGT inhibitors.
Conclusions
PGTs are an important class of enzymes, which catalyze the first membrane-committed step in glycoconjugate biosynthesis in both prokaryotes and eukaryotes. Despite their significance and potential as therapeutic targets, the PGT enzymes are relatively underexplored, largely due to difficulties in expressing, purifying and assaying these integral membrane proteins. Nonetheless, the advancement of technologies such as Nanodiscs (Bayburt and Sligar 2010) and lipid super-structures (Barauskas et al. 2005 ) as alternative platforms for stabilizing membrane proteins in a more native-like environment provide promising opportunities for the characterization of PGTs. Bioinformatics analysis and mutational studies have provided insight into conserved residues found in the two PGT superfamilies (Amer and Valvano 2001; Lukose et al. 2015) . Furthermore, advances in genome sequencing have dramatically increased the pool of data available for such types of analyses, and have demonstrated that the PGTs discussed in this review are representative of thousands of homologs in other bacterial glycoconjugate biosynthesis pathways. Additionally, the successful structure determination of MraY, both with and without bound inhibitors, has tremendously increased our understanding of the functionally-significant residues in the polytopic PGT superfamily. Therefore, inhibitor development may now be guided by structural information, which will accelerate the process of finding novel classes of antimicrobials. Additionally, the progress made in identifying members of a second major PGT superfamily has paved the way for our understanding of PGTs that have yet to be discovered. There is no doubt that structural and mechanistic studies will also form an important foundation for inhibitor development targeted at the broad emerging superfamily of proteins that includes the common PglC-like core.
Finally, PGTs offer promising opportunities in the field of glycoengineering. Bacterial genes encoding enzymes responsible for the synthesis and processing of Pren-PP-linked glycans are generally clustered in operons in bacterial genomes. Using bioinformatics analysis, these gene clusters can be identified (Kumar and Balaji 2011) and expressed heterologously in tractable bacterial expression systems for large-scale biosynthesis of complex glycoconjugates. Together, a detailed structural and functional characterization of PGTs and related GTs in pathways from both symbiotic and pathogenic bacteria could provide both novel antimicrobial targets and diverse sets of glycoconjugates for a variety of biotechnological applications.
Funding

